Corient Private Wealth
GNOM icon

Corient Private Wealth’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Corient Private Wealth’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,500
Closed -$102K – 2284
2023
Q3 		$102K Buy
+2,500
New +$114K ﹤0.01% 2021

Other funds holding GNOM

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Corient Private Wealth's GNOM Position: Q4 2023 in Review

Corient Private Wealth sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2023, closing a stake of 2,500 shares — an estimated $102K sold.

Corient Private Wealth first reported a position in GNOM in Q3 2023 and held it in 1 quarter. The position peaked at $102K in Q3 2023. 61 funds tracked by Wall St. Rank hold GNOM as of Q4 2023.

  • Corient Private Wealth reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
  • Corient Private Wealth sold 2,500 Global X Genomics & Biotechnology ETF shares in Q4 2023, an estimated $102K.
  • Corient Private Wealth first reported a position in Global X Genomics & Biotechnology ETF in Q3 2023 and held it in 1 quarter.
  • Corient Private Wealth's Global X Genomics & Biotechnology ETF position peaked at $102K in Q3 2023.
  • 61 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2023.

Based on Corient Private Wealth's 13F filing for Q4 2023, filed 9 Feb 2024.